PLoS ONE (Jan 2023)

Development of diagnostic and point of care assays for a gammaherpesvirus infecting koalas.

  • Belinda R Wright,
  • Martina Jelocnik,
  • Andrea Casteriano,
  • Yasmine S S Muir,
  • Alistair R Legione,
  • Paola K Vaz,
  • Joanne M Devlin,
  • Damien P Higgins

DOI
https://doi.org/10.1371/journal.pone.0286407
Journal volume & issue
Vol. 18, no. 6
p. e0286407

Abstract

Read online

The recent listing of koala populations as endangered across much of their range has highlighted the need for better management interventions. Disease is a key threat to koala populations but currently there is no information across the threatened populations on the distribution or impact of a gammaherpesvirus, phascolarctid gammaherpesvirus 1 (PhaHV-1). PhaHV-1 is known to infect koalas in southern populations which are, at present, not threatened. Current testing for PhaHV-1 involves lengthy laboratory techniques that do not permit quantification of viral load. In order to better understand distribution, prevalence and impacts of PhaHV-1 infections across koala populations, diagnostic and rapid point of care tests are required. We have developed two novel assays, a qPCR assay and an isothermal assay, that will enable researchers, clinicians and wildlife managers to reliably and rapidly test for PhaHV-1 in koalas. The ability to rapidly diagnose and quantify viral load will aid quarantine practices, inform translocation management and guide research into the clinical significance and impacts of PhaHV-1 infection in koalas.